Despite this, PLpro remains an underused drug target. WEHI-P8’s unique binding mechanism disrupts PLpro’s ability to hijack human proteins, blocking both viral replication and its evasion of ...

The world-first study found mice treated with the antiviral compound, developed by a multidisciplinary research team at WEHI, were protected from long term brain and lung dysfunction – key ...